You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

neuroendocrine prostate cancer (NEPC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

Not yet recruiting
  • Small Cell Lung Cancer (SCLC)
  • +3 more
  • (no location specified)
Dec 7, 2022

Advanced Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Neuroendocrine Carcinoma Trial in Boston

Not yet recruiting
  • Advanced Prostate Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Sep 25, 2023

Metastatic Malignant Tumor in the Viscera, Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic

Not yet recruiting
  • Metastatic Malignant Neoplasm in the Viscera
  • +4 more
  • Lutetium Lu 177 Dotatate
  • (no location specified)
Jan 25, 2023

Prostate Cancer Metastatic, Neuroendocrine Tumors Trial in Atlanta, Ann Arbor (Pembrolizumab, Lenvatinib)

Recruiting
  • Prostate Cancer Metastatic
  • Neuroendocrine Tumors
  • Duarte, California
  • +2 more
Jan 18, 2023

Prostate Cancer Trial in Durham (Copper, Disulfiram, Copper gluconate)

Terminated
  • Prostate Cancer
  • Durham, North Carolina
    Duke University Medical Center
Sep 13, 2021

Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

Not yet recruiting
  • Prostate Carcinoma
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2023

Tumor Recurrence Following Radiotherapy

Recruiting
  • Prostate Cancer
    • Rochester, Minnesota
      Mayo Clinic
    Jan 20, 2023

    Small Cell Neuroendocrine Carcinoma, Prostate Cancer, Small Cell Carcinoma Trial in San Francisco (Apalutamide, Cetrelimab)

    Recruiting
    • Small Cell Neuroendocrine Carcinoma
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Mar 21, 2022

    Castration-Resistant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen

    Recruiting
    • Castration-Resistant Prostate Carcinoma
    • +7 more
    • Biopsy
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 12, 2022

    Prostate Cancer Trial in Durham (Avelumab)

    Completed
    Has Results
    • Prostate Cancer
    • Durham, North Carolina
      Duke University Medical Center
    Feb 12, 2021

    Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Seattle

    Active, not recruiting
    • Castration-Sensitive Prostate Carcinoma
    • +7 more
    • Antiandrogen Therapy
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Sep 8, 2022

    Metastatic Prostate Cancer, Neuroendocrine Prostate Cancer Trial in Detroit, New York, Lancaster (ORIC-944)

    Recruiting
    • Metastatic Prostate Cancer
    • Neuroendocrine Prostate Cancer
    • Detroit, Michigan
    • +2 more
    Sep 19, 2022

    Bladder Small Cell Neuroendocrine Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Bladder Urothelial Carcinoma

    Recruiting
    • Bladder Small Cell Neuroendocrine Carcinoma
    • +16 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Mar 23, 2022

    Neuroendocrine Prostate Cancer Trial in Worldwide (Tarlatamab)

    Recruiting
    • Neuroendocrine Prostate Cancer
    • Phoenix, Arizona
    • +19 more
    Aug 11, 2022

    Advanced Malignant Solid Tumor, Anal Carcinoma, Biliary Tract Carcinoma Trial in Jacksonville (Clinical Encounter, Home Health

    Not yet recruiting
    • Advanced Malignant Solid Neoplasm
    • +18 more
    • Clinical Encounter
    • +3 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Jul 24, 2023

    Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in United States (JBI-802)

    Recruiting
    • Locally Advanced Solid Tumor
    • Metastatic Solid Tumor
    • Denver, Colorado
    • +3 more
    Aug 19, 2022

    Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in Atlanta (CT

    Active, not recruiting
    • Castration-Resistant Prostate Carcinoma
    • +2 more
    • CT (Computed Tomography)
    • +2 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Mar 3, 2022

    Neuroendocrine Tumors, Prostate Cancer Trial in Salt Lake City (Single-Tracer FDG PET/CT Exam, Single-Tracer Cu64-DOTATATE

    Recruiting
    • Neuroendocrine Tumors
    • Prostate Cancer
    • Single-Tracer FDG PET/CT Exam
    • +3 more
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Dec 27, 2022

    Anal Squamous Cell Carcinoma, Colorectal Tumors, Soft Tissue Sarcoma Trial (Regorafenib in combination with Tislelizumab)

    Not yet recruiting
    • Anal Squamous Cell Carcinoma
    • +7 more
    • Regorafenib in combination with Tislelizumab
    • (no location specified)
    Oct 12, 2022

    Aggressive Variant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Houston

    Recruiting
    • Aggressive Variant Prostate Carcinoma
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 10, 2022

    Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Without Neuroendocrine Differentiation, Stage IV Prostate

    Suspended
    • Castration-Resistant Prostate Carcinoma
    • +4 more
    • Abiraterone Acetate
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 27, 2022

    Genitourinary Cancer, Adrenocortical Carcinoma, Non-urothelial Bladder Trial in United States (Ipilimumab, Nivolumab)

    Recruiting
    • Genitourinary Cancer
    • +7 more
    • La Jolla, California
    • +5 more
    Jul 5, 2022

    Medullary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroid Carcinoma, Medullary Trial in Groningen (18F-PSMA-1007)

    Not yet recruiting
    • Medullary Thyroid Cancer
    • +3 more
    • Groningen, Netherlands
      University Medical Centre Groningen
    Sep 8, 2022

    Pancreatic Ductal Adenocarcinoma (PDAC), Squamous Cell Carcinoma of Head and Neck, Colorectal Cancer Trial in Omaha

    Recruiting
    • Pancreatic Ductal Adenocarcinoma (PDAC)
    • +6 more
    • Omaha, Nebraska
      Urology Cancer Center/XCancer
    Nov 29, 2022

    Thyroid Cancer, Prostate Cancer, Neuroendocrine Tumors Trial in Montpellier (Biological collection)

    Recruiting
    • Thyroid Cancer
    • +2 more
    • Biological collection
    • Montpellier, France
      Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
    Nov 3, 2021